Skip to main content
. 2021 Apr 23;2:648428. doi: 10.3389/fgwh.2021.648428

Figure 1.

Figure 1

Rates of clinically elevated anxiety and depression symptoms in pregnant individuals in this study were compared to pre-pandemic meta-analysis estimates, and meta-analysis estimates of rates during the COVID-19 pandemic. The prevalence in the current study is given, vs. the estimated ranges in prior studies. The frequency of clinically elevated symptoms of anxiety (orange) and depression (red) in the current study were substantially higher than pre-pandemic and during-pandemic estimates, likely because this data was collected early in the COVID-19 pandemic (April–June 2020) when uncertainty was at its highest. References 1, Tomfohr-Madsen et al. (33); 2, Dennis et al. (34); 3, Gavin et al. (35).